| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Perspective Therapeutics, Inc. (CATX) has 8 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. CATX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 735.0K | $2.21M | - | |
| CFO | 600.0K | $1.80M | - | |
| Other | 150.0K | $450.0K | - | |
| Other | 90.0K | $270.0K | - | |
| Dir | 75.0K | $225.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25, 2024 | Williamson Robert F III63 | Director | Buy | 51,996 | $0.49 | $25,478.04 | +67.3% | +228.8% | -22.0% | |
| Jan 24, 2024 | Puhlmann Markus60 | Chief Medical Officer | Buy | 280,000 | $0.50 | $139,888.00 | +25.6% | +247.9% | -25.7% | |
| Dec 21, 2023 | Williamson Robert F III63 | Director | Buy | 3,663 | $0.33 | $1,202.56 | New | +258.0% | -15.0% | |
| Dec 19, 2023 | Williamson Robert F III63 | Director | Buy | 23,680 | $0.29 | $6,977.60 | +236.8% | +185.8% | -12.1% | |
| Dec 19, 2023 | Puhlmann Markus60 | Chief Medical Officer | Buy | 595,425 | $0.32 | $188,737.33 | +32.5% | +185.8% | -12.1% | |
| Dec 18, 2023 | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 125,000 | $0.26 | $32,337.50 | +65.2% | +272.6% | +18.5% | |
| Dec 15, 2023 | Woods Lori A70 | Director | Buy | 185,200 | $0.27 | $49,988.70 | +6.9% | +299.7% | +30.0% | |
| Dec 5, 2022 | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 85,404 | $0.38 | $32,501.40 | +32.1% | +27.4% | -23.1% | |
| Nov 15, 2022 | Woods Lori A70 | CEO | Buy | 100,000 | $0.34 | $33,540.00 | +9.6% | +12.1% | -23.7% | |
| Jun 9, 2022 | Austin Mark John | VP Finance/ Prin Fin&Acct Offic | Buy | 18,800 | $0.29 | $5,384.22 | +24.9% | +21.1% | +81.2% |